RTI International is adding 10 employees and an office in Ottawa, Canada, to its RTI Health Solutions business group.

RTI said Tuesday it had closed on the acquisition of Palmer D’Angelo Consulting, or PDCI, a pharmaceutical and reimbursement consulting company. Terms were not disclosed.

The firm’s 10 employees, including its two co-founders, have joined RTI.

RTI was looking for expertise in the areas in which the PDCI firm practiced, according to an RTI spokesperson.

“We were looking for expertise across the marketplace,” the spokesperson said. “They had a great reputation,” she added about PDCI.

The company will operate as a wholly owned subsidiary of RTI.

“The acquisition will allow RTI Health Solutions to better serve pharmaceutical companies as they develop pricing and reimbursement strategies and seek formulary access for their drugs,” RTI said in a statement. PDCI works with companies around the world.

"Adding pricing and reimbursement expertise is synergistic with our portfolio of health economics and outcomes-research services," said Allen Mangel, vice president of RTI Health Solutions.

Neil Palmer and Janice D’Angelo, co-founders and principals at PDCI, have joined RTI as vice president of pricing and reimbursement and global head of pricing and reimbursement Canada, respectively.

"We are very pleased to welcome these talented professionals to our RTI family," said RTI President Victoria Haynes in a statement. "Their addition will strengthen RTI Health Solutions’ leadership position in helping our clients develop and commercialize their new products."

RTI established RTI Health Solutions in 2000. The group has more than 115 employees in the U.S. and Europe as well as Canada with experts in epidemiology, biostatistics, health economics, psychometrics, reimbursement strategy, medical writing and clinical development.

PDCI was launched in 1996.